Search

Your search keyword '"Luminari, Stefano"' showing total 1,024 results
Start Over Author "Luminari, Stefano"
1,024 results on '"Luminari, Stefano"'

1. End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial

Author

Guerra, Luca, Chauvie, Stephane, Fallanca, Federico, Bergesio, Fabrizio, Marcheselli, Luigi, Durmo, Rexhep, Peano, Simona, Franceschetto, Antonella, Monaco, Lavinia, Barbieri, Emiliano, Ladetto, Marco, Musuraca, Gerardo, Tosi, Patrizia, Bianchi, Benedetta, Bolis, Silvia Anna Maria, Pavone, Vincenzo, Chiarenza, Annalisa, Arcari, Annalisa, Califano, Catello, Bari, Alessia, Massaia, Massimo, Conconi, Annarita, Musto, Pellegrino, Mannina, Donato, Roti, Giovanni, Galimberti, Sara, Gini, Guido, Falcinelli, Flavio, Vitolo, Umberto, Usai, Sara Veronica, Stefani, Piero Maria, Ibatici, Adalberto, Liberati, Anna Marina, Pennese, Elsa, Perrone, Tommasina, Versari, Annibale, and Luminari, Stefano

Published
2024
Full Text
View/download PDF

2. Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial

Author

Pulsoni, Alessandro, Ferrero, Simone, Tosti, Maria Elena, Luminari, Stefano, Dondi, Alessandra, Cavallo, Federica, Merli, Francesco, Liberati, Anna Marina, Cenfra, Natalia, Renzi, Daniela, Zanni, Manuela, Boccomini, Carola, Ferreri, Andrés J M, Rattotti, Sara, Zilioli, Vittorio Ruggero, Bolis, Silvia Anna, Bernuzzi, Patrizia, Musuraca, Gerardo, Gaidano, Gianluca, Perrone, Tommasina, Stelitano, Caterina, Tucci, Alessandra, Corradini, Paolo, Bigliardi, Sara, Re, Francesca, Cencini, Emanuele, Mannarella, Clara, Mannina, Donato, Celli, Melania, Tani, Monica, Annechini, Giorgia, Assanto, Giovanni Manfredi, Grapulin, Lavinia, Guarini, Anna, Cavalli, Marzia, De Novi, Lucia Anna, Bomben, Riccardo, Ciabatti, Elena, Genuardi, Elisa, Drandi, Daniela, Della Starza, Irene, Arcaini, Luca, Ricardi, Umberto, Gattei, Valter, Galimberti, Sara, Ladetto, Marco, Foà, Robin, and Del Giudice, Ilaria

Published
2024
Full Text
View/download PDF

3. Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment

Author

Arcaini, Luca, Bommier, Côme, Alderuccio, Juan Pablo, Merli, Michele, Fabbri, Nicole, Nizzoli, Maria Elena, Maurer, Matthew J., Tarantino, Vittoria, Ferrero, Simone, Rattotti, Sara, Talami, Annalisa, Murru, Roberta, Khurana, Arushi, Mwangi, Raphael, Deodato, Marina, Cencini, Emanuele, Re, Francesca, Visco, Carlo, Feldman, Andrew L., Link, Brian K., Delamain, Marcia Torresan, Spina, Michele, Annibali, Ombretta, Pulsoni, Alessandro, Ferreri, Andrés J.M., Stelitano, Caterina Cecilia, Pennese, Elsa, Habermann, Thomas M., Marcheselli, Luigi, Han, Sunwoo, Reis, Isildinha M., Paulli, Marco, Lossos, Izidore S., Cerhan, James R., and Luminari, Stefano

Published
2024
Full Text
View/download PDF

4. PET-Bildgebung

Author

Luminari, Stefano, Trotman, Judith, Dreyling, Martin, editor, and Ladetto, Marco, editor

Published
2023
Full Text
View/download PDF

5. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

Author

Gini, Guido, Tani, Monica, Tucci, Alessandra, Marcheselli, Luigi, Cesaretti, Marina, Bellei, Monica, Pascarella, Anna, Ballerini, Filippo, Petrini, Mauro, Merli, Francesco, Olivieri, Attilio, Lanza, Francesco, Annibali, Ombretta, Zilioli, Vittorio Ruggero, Liberati, Anna Marina, Tisi, Maria Chiara, Arcari, Annalisa, Marino, Dario, Musuraca, Gerardo, Pavone, Vincenzo, Fabbri, Alberto, Pozzi, Samantha, Mannina, Donato, Plenteda, Caterina, Celli, Melania, and Luminari, Stefano

Published
2023
Full Text
View/download PDF

6. The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

Author

Hapgood, Greg, Civallero, Monica, Stepanishyna, Yana, Vose, Julie, Cabrera, Monica Elena, Advani, Ranjana H., Pileri, Stefano A., Manni, Martina, Horwitz, Steven M., Foss, Francine M., Hitz, Felicitas, Radford, John, Dlouhy, Ivan, Chiattone, Carlos, Kim, Won Seog, Skrypets, Tetiana, Nagler, Arnon, Trotman, Judith, Luminari, Stefano, and Federico, Massimo

Published
2023
Full Text
View/download PDF

7. A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma

Author

Arcari, Annalisa, Rigacci, Lugi, Tucci, Alessandra, Puccini, Benedetta, Usai, Sara Veronica, Cavallo, Federica, Fabbri, Alberto, Balzarotti, Monica, Pelliccia, Sabrina, Luminari, Stefano, Pennese, Elsa, Zilioli, Vittorio Ruggero, Mahmoud, Abdurraouf Mokhtar, Musuraca, Gerardo, Marino, Dario, Sartori, Roberto, Botto, Barbara, Gini, Guido, Zanni, Manuela, Hohaus, Stefan, Tarantini, Giuseppe, Flenghi, Leonardo, Tani, Monica, Di Rocco, Alice, Merli, Michele, Vallisa, Daniele, Pagani, Chiara, Nassi, Luca, Dessì, Daniela, Ferrero, Simone, Cencini, Emanuele, Bernuzzi, Patrizia, Mammi, Caterina, Marcheselli, Luigi, Tabanelli, Valentina, Spina, Michele, and Merli, Francesco

Published
2023
Full Text
View/download PDF

8. IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study

Author

Cox, M. Christina, Marcheselli, Luigi, Scafetta, Giorgia, Visco, Carlo, Hohaus, Stefan, Annibali, Ombretta, Musuraca, Gerardo, Fabbri, Alberto, Cantonetti, Maria, Pelliccia, Sabrina, Papotti, Robel, Petrucci, Luigi, Tani, Monica, Battistini, Roberta, Arcari, Annalisa, Luminari, Stefano, Lopez, Gianluca, Alma, Eleonora, Pupo, Livio, Carli, Giuseppe, Marchesi, Francesco, Re, Francesca, Scarpino, Stefania, D’amore, Emanuele S. G., Larocca, Luigi M., Bianchi, Antonella, Pepe, Giuseppina, Natalino, Fiammetta, Anticoli-Borza, Paola, Cenfra, Natalia, Andriani, Alessandro, Abruzzese, Elisabetta, Tesei, Cristiano, Leoncini, Lorenzo, Asioli, Silvia, Ruco, Luigi, and Di Napoli, Arianna

Published
2022
Full Text
View/download PDF

9. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

Author

Nanni, Cristina, Kobe, Carsten, Baeßler, Bettina, Baues, Christian, Boellaard, Ronald, Borchmann, Peter, Buck, Andreas, Buvat, Irène, Chapuy, Björn, Cheson, Bruce D, Chrzan, Robert, Cottereau, Ann-Segolene, Dührsen, Ulrich, Eikenes, Live, Hutchings, Martin, Jurczak, Wojciech, Kraeber-Bodéré, Françoise, Lopci, Egesta, Luminari, Stefano, MacLennan, Steven, Mikhaeel, N George, Nijland, Marcel, Rodríguez-Otero, Paula, Treglia, Giorgio, Withofs, Nadia, Zamagni, Elena, Zinzani, Pier Luigi, Zijlstra, Josée M, Herrmann, Ken, and Kunikowska, Jolanta

Published
2023
Full Text
View/download PDF

10. Results from the follicular lymphoma (FL) outcomes in patients (pts) with relapsed/refractory (R/R) disease treated with systemic therapy in a real-world assessment (FLORA) study.

Author

Luminari, Stefano, primary, Harnett, James, additional, Thieblemont, Catherine, additional, Prochazka, Katharina, additional, Townsend, William, additional, Radford, John, additional, Serna, Ángel, additional, Jalbert, Jessica J, additional, Kamat, Siddhesh, additional, Wang, Joy, additional, Ambati, Srikanth R, additional, Mohamed, Hesham, additional, Chaudhry, Aafia, additional, Sanz, Hector, additional, Hermans, Ruben, additional, Maissenhaelter, Benedikt, additional, Hampp, Christian, additional, and Bachy, Emmanuel, additional

Published
2024
Full Text
View/download PDF

11. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

Author

Alderuccio, Juan Pablo, Arcaini, Luca, Watkins, Marcus P., Beaven, Anne W., Shouse, Geoffrey, Epperla, Narendranath, Spina, Michele, Stefanovic, Alexandra, Sandoval-Sus, Jose, Torka, Pallawi, Alpert, Ash B., Olszewski, Adam J., Kim, Seo-Hyun, Hess, Brian, Gaballa, Sameh, Ayyappan, Sabarish, Castillo, Jorge J., Argnani, Lisa, Voorhees, Timothy J., Saba, Raya, Chowdhury, Sayan Mullick, Vargas, Fernando, Reis, Isildinha M., Kwon, Deukwoo, Alexander, Jonathan S., Zhao, Wei, Edwards, Dali, Martin, Peter, Cencini, Emanuele, Kamdar, Manali, Link, Brian K., Logothetis, Constantine N., Herrera, Alex F., Friedberg, Jonathan W., Kahl, Brad S., Luminari, Stefano, Zinzani, Pier Luigi, and Lossos, Izidore S.

Published
2022
Full Text
View/download PDF

12. PET Imaging

Author

Luminari, Stefano, Trotman, Judith, Dreyling, Martin, Series Editor, and Ladetto, Marco, editor

Published
2021
Full Text
View/download PDF

15. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma

Author

Stathis, Anastasios, primary, Pirosa, Maria Cristina, additional, Orsucci, Lorella, additional, Feugier, Pierre, additional, Tani, Monica, additional, Ghesquières, Hervé, additional, Musuraca, Gerardo, additional, Rossi, Francesca Gaia, additional, Merli, Francesco, additional, Guièze, Romain, additional, Gyan, Emmanuel, additional, Gini, Guido, additional, Marino, Dario, additional, Gressin, Remy, additional, Morschhauser, Franck, additional, Cavallo, Federica, additional, Palombi, Francesca, additional, Conconi, Annarita, additional, Tessoulin, Benoît, additional, Tilly, Hervé, additional, Zanni, Manuela, additional, Cabras, Maria Giuseppina, additional, Capochiani, Enrico, additional, Califano, Catello, additional, Celli, Melania, additional, Pulsoni, Alessandro, additional, Angrilli, Francesco, additional, Occhini, Ubaldo, additional, Casasnovas, René-Olivier, additional, Cartron, Guillaume, additional, Devizzi, Liliana, additional, Haioun, Corinne, additional, Liberati, Anna Marina, additional, Houot, Roch, additional, Merli, Michele, additional, Pietrantuono, Giuseppe, additional, Re, Francesca, additional, Spina, Michele, additional, Landi, Francesco, additional, Cavalli, Franco, additional, Bertoni, Francesco, additional, Rossi, Davide, additional, Ielmini, Nicoletta, additional, Borgo, Elena, additional, Luminari, Stefano, additional, Zucca, Emanuele, additional, and Thieblemont, Catherine, additional

Published
2024
Full Text
View/download PDF

16. Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

Author

Luminari, Stefano, Fossa, Alexander, Trotman, Judith, Molin, Daniel, d'Amore, Francesco, Enblad, Gunilla, Berkahn, Leanne, Barrington, Sally F., Radford, John, Federico, Massimo, Kirkwood, Amy A., Johnson, Peter W. M., Luminari, Stefano, Fossa, Alexander, Trotman, Judith, Molin, Daniel, d'Amore, Francesco, Enblad, Gunilla, Berkahn, Leanne, Barrington, Sally F., Radford, John, Federico, Massimo, Kirkwood, Amy A., and Johnson, Peter W. M.

Abstract

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. We analyzed long-term results of the response-adapted trial for adult patients with advanced-stage Hodgkin lymphoma. The aim was to confirm noninferiority of treatment de-escalation by omission of bleomycin from doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) for interim fluorodeoxyglucose positron emission tomography (iPET)–negative patients and assess efficacy and long-term safety for iPET-positive patients who underwent treatment intensification with escalated bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisolone (BEACOPP/BEACOPP14). The median follow-up is 7.3 years. For all patients, the 7-year progression-free survival (PFS) and overall survival (OS) are 78.2% (95% CI, 75.6 to 80.5) and 91.6% (95% CI, 89.7 to 93.2), respectively. The 1.3% difference in 3-year PFS (95% CI, –3.0 to 4.7) between ABVD and doxorubicin, vinblastine, and dacarbazine (AVD) now falls within the predefined noninferiority margin. Among 172 patients with positive iPET, the 7-year PFS was 65.9% (95% CI, 58.1 to 72.6) and the 7-year OS was 83.2% (95% CI, 76.2 to 88.3). The cumulative incidence of second malignancies at 7 years was 5.5% (95% CI, 4.0 to 7.5) for those receiving ABVD/AVD and 2.5% (95% CI, 0.8 to 7.7) for those escalated to BEACOPP. With extended follow-up, these results confirm noninferiority of treatment de-escalation after a negative iPET. Escalation with BEACOPP for iPET-positive patients is effective and safe, with no increase in second malignancies.

Published
2024
Full Text
View/download PDF

17. Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project.

Author

Civallero, Monica, Schroers‐Martin, Joseph G., Horwitz, Steven, Manni, Martina, Stepanishyna, Yana, Cabrera, Maria Elena, Vose, Julie, Spina, Michele, Hitz, Felicitas, Nagler, Arnon, Montoto, Silvia, Chiattone, Carlos, Skrypets, Tetiana, Perez Saenz, M. Angeles, Priolo, Giorgio, Luminari, Stefano, Lymboussaki, Athina, Pavlovsky, Astrid, Marino, Dario, and Liberati, Marina

Subjects
T cells, T-cell lymphoma, LYMPHOMAS, PATIENT experience, THERAPEUTICS
Abstract

Summary: Peripheral T‐cell lymphomas (PTCLs) are a heterogeneous group of haematological cancers with generally poor clinical outcomes. However, a subset of patients experience durable disease control, and little is known regarding long‐term outcomes. The International T‐cell Lymphoma Project (ITCLP) is the largest prospectively collected cohort of patients with PTCLs, providing insight into clinical outcomes at academic medical centres globally. We performed a long‐term outcome analysis on patients from the ITCLP with available 10‐year follow‐up data (n = 735). The overall response rate to first‐line therapy was 68%, while 5‐ and 10‐year overall survival estimates were 49% and 40% respectively. Most deaths occurred prior to 5 years, and for patients alive at 5 years, the chance of surviving to 10 years was 84%. However, lymphoma remained the leading cause of death in the 5‐ to 10‐year period (67%). Low‐risk International Prognostic Index and Prognostic Index for T‐cell lymphoma scores both identified patients with improved survival, while in multivariate analysis, age >60 years and Eastern Cooperative Oncology Group performance status 2–4 were associated with inferior outcomes. The favourable survival seen in patients achieving durable initial disease control emphasizes the unmet need for optimal front‐line therapeutic approaches in PTCLs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Curative intent therapy for DLBCL in the elderly.

Author

Tucci, Alessandra, Masina, Lorenzo, and Luminari, Stefano

Subjects
DIFFUSE large B-cell lymphomas, OLDER patients, OLDER people, GERIATRIC assessment, PHYSICIANS
Abstract

Older patients with aggressive lymphoma are extremely heterogeneous due to the high frequency of functional limitations and comorbidities and to the different biological profiles and clinical behavior of the disease. The stratification in three geriatric categories (fit-unfit-frail) based on multidimensional geriatric assessment (GA) helps physicians tailor a potentially curative treatment. While an intensive approach with the standard R-CHOP regimen is feasible in fit patients, leading to similar long-term response and survival rates compared to younger ones, in unfit patients a balance between treatment toxicity and curative intent can be obtained through the reduction of dose intensity. Frail patients, treated with best supportive care so far, could benefit from a chemo-free approach with new target drugs. These novel agents, either alone or in combination with chemo-immunotherapy, are changing the therapeutic landscape of older patients with aggressive lymphoma, both in first-line therapy and in the setting of the relapsed/refractory disease. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Author

Santoro, Armando, Mazza, Rita, Pulsoni, Alessandro, Re, Alessandro, Bonfichi, Maurizio, Zilioli, Vittorio Ruggero, Zanni, Manuela, Merli, Francesco, Anastasia, Antonella, Luminari, Stefano, Annechini, Giorgia, Gotti, Manuel, Peli, Annalisa, Liberati, Anna Marina, Di Renzo, Nicola, Castagna, Luca, Giordano, Laura, Ricci, Francesca, and Carlo-Stella, Carmelo

Published
2020
Full Text
View/download PDF

21. Local Radiotherapy and MRD-Driven Immunotherapy in Early-Stage Follicular Lymphoma: Final Results of the FIL - 'MIRO' Multicenter Phase II Trial

Author

Pulsoni, Alessandro, primary, Ferrero, Simone, additional, Tosti, Maria Elena, additional, Luminari, Stefano, additional, Dondi, Alessandra, additional, Cavallo, Federica, additional, Merli, Francesco, additional, Liberati, Anna Marina, additional, Cenfra, Natalia, additional, Renzi, Daniela, additional, Zanni, Manuela, additional, Boccomini, Carola, additional, Ferreri, Andrés, additional, Rattotti, Sara, additional, Zilioli, Vittorio Ruggero, additional, Bolis, Silvia Anna, additional, Bernuzzi, Patrizia, additional, Musuraca, Gerardo, additional, Gaidano, Gianluca, additional, Perrone, Tommasina, additional, Stelitano, Caterina, additional, Tucci, Alessandra, additional, Corradini, Paolo, additional, Bigliardi, Sara, additional, Re, Francesca, additional, Cencini, Emanuele, additional, Mannarella, Clara, additional, Mannina, Donato, additional, Celli, Melania, additional, Tani, Monica, additional, Annechini, Giorgia, additional, Assanto, Giovanni Manfredi, additional, Grapulin, Lavinia, additional, Guarini, Anna, additional, Cavalli, Marzia, additional, De Novi, Lucia Anna, additional, Bomben, Riccardo, additional, Ciabatti, Elena, additional, Genuardi, Elisa, additional, Drandi, Daniela, additional, Della Starza, Irene, additional, Arcaini, Luca, additional, Ricardi, Umberto, additional, Gattei, Valter, additional, Galimberti, Sara, additional, Ladetto, Marco, additional, Foà, Robin, additional, and del Giudice, Ilaria, additional

Published
2024
Full Text
View/download PDF

22. Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi

Author

Merli, Michele, Luminari, Stefano, Farina, Lucia, Cocito, Federica, Defrancesco, Irene, Gini, Guido, Arcari, Annalisa, Scapinello, Greta, Gentile, Massimo, Goldaniga, Maria, Loseto, Giacomo, Cencini, Emanuele, Greco, Antonino, Molinari, Anna Lia, Ferrario, Andrea, Bianchi, Benedetta, Mora, Barbara, Bertù, Lorenza, Saturni, Vincenzo, Bergamini, Fabio, Fabbri, Nicole, Rossi, Francesca Gaia, Bolis, Silvia, Passamonti, Francesco, and Arcaini, Luca

Published
2020
Full Text
View/download PDF

23. Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the “Gruppo Italiano Trapianto di Midollo Osseo”

Author

Botti, Stefano, Agreiter, Iris, Orlando, Laura, Gargiulo, Gianpaolo, Bonifazi, Francesca, Banfi, Marina Marialuisa, Cappucciati, Lorella, Caffarri, Cristiana, De Cecco, Valentina, Deiana, Giuseppe Marco, Gavezzotti, Marta, Magarò, Antonio, Netti, Maria Giovanna, Pignatelli, Adriana Concetta, Rostagno, Elena, Samarani, Emanuela, Cardoso, Janini Silva, Soave, Sonia, Valente, Concetta Maria, Vedovetto, Alessio, Zecca, Marco, Luminari, Stefano, Merli, Francesco, and Guberti, Monica

Published
2020
Full Text
View/download PDF

25. Radioimmunotherapy of Lymphomas

Author

Luminari, Stefano, Morbelli, Silvia, Garaboldi, Lucia, Ferrari, Mahila Esmeralda, Biggi, Alberto, Bombardieri, Emilio, editor, Seregni, Ettore, editor, Evangelista, Laura, editor, Chiesa, Carlo, editor, and Chiti, Arturo, editor

Published
2018
Full Text
View/download PDF

26. Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

Author

Luminari, Stefano, primary, Fossa, Alexander, additional, Trotman, Judith, additional, Molin, Daniel, additional, d'Amore, Francesco, additional, Enblad, Gunilla, additional, Berkahn, Leanne, additional, Barrington, Sally F., additional, Radford, John, additional, Federico, Massimo, additional, Kirkwood, Amy A., additional, and Johnson, Peter W.M., additional

Published
2023
Full Text
View/download PDF

27. PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1)

Author

Luminari, Stefano, primary, Kim, Tae Min, additional, Risal, Ashish, additional, Namuduri, Manjusha, additional, Cai, Jingxian, additional, Fearon-Chalet, Bertha, additional, Zhu, Min, additional, Mukherjee, Sushmita, additional, Brouwer-Visser, Jurriaan, additional, Chaudhry, Aafia, additional, Mohamed, Hesham, additional, Ambati, Srikanth, additional, and Vitolo, Umberto, additional

Published
2023
Full Text
View/download PDF

28. Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study

Author

Besutti, Giulia, primary, Marvisi, Chiara, additional, Mancuso, Pamela, additional, Farì, Roberto, additional, Monelli, Filippo, additional, Revelli, Matteo, additional, Durmo, Rexhep, additional, Galli, Elena, additional, Muratore, Francesco, additional, Spaggiari, Lucia, additional, Ottone, Marta, additional, Luminari, Stefano, additional, Pattacini, Pierpaolo, additional, Giorgi Rossi, Paolo, additional, and Salvarani, Carlo, additional

Published
2023
Full Text
View/download PDF

29. P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2

Author

Taszner, Michał, primary, Luminari, Stefano, additional, Cho, Seok-Goo, additional, Novelli, Silvana, additional, Le Gouill, Steven, additional, Poon, Michelle, additional, Villasboas, Jose, additional, Champion, Rebecca, additional, Bachy, Emmanuel, additional, Guidez, Stephanie, additional, Alonso Alonso, Aránzazu, additional, Jagadeesh, Deepa, additional, Merli, Michele, additional, Tucker, David, additional, Cai, Jingxian, additional, Leite de Oliveira, Carolina, additional, Zhu, Min, additional, Chaudhry, Aafia, additional, Mohamed, Hesham, additional, Ambati, Srikanth, additional, and Min Kim, Tae, additional

Published
2023
Full Text
View/download PDF

31. ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

Author

Buske, Christian, Dreyling, Martin, Ferreri, Andrés J M, Fields, Paul, Gaidano, Gianluca, Goede, Valentin, Hutchings, Martin, Ladetto, Marco, Le Gouill, Steven, Luminari, Stefano, Mey, Ulrich, de Nully Brown, Peter, Pfreundschuh, Michael, Pott, Christiane, Schmitz, Norbert, Soubeyran, Pierre, Spina, Michele, Stauder, Reinhard, Balari, Anna Sureda, Trněný, Marek, van Imhoff, Gustaaf, Walewski, Jan, Wedding, Ulrich, Zamò, Alberto, Zucca, Emanuele, Buske, C., Hutchings, M., Ladetto, M., Goede, V., Mey, U., Soubeyran, P., Spina, M., Stauder, R., Trněný, M., Wedding, U., and Fields, P.

Published
2018
Full Text
View/download PDF

32. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020

Author

Mangone, Lucia, primary, Penna, Domenico, additional, Marinelli, Francesco, additional, Roncaglia, Francesca, additional, Bisceglia, Isabella, additional, Merli, Francesco, additional, Ruffini, Alessia, additional, Gamberi, Barbara, additional, Tieghi, Alessia, additional, Valli, Riccardo, additional, Albertazzi, Laura, additional, Iori, Mauro, additional, Giorgi Rossi, Paolo, additional, Vener, Claudia, additional, Morabito, Fortunato, additional, Neri, Antonino, additional, and Luminari, Stefano, additional

Published
2023
Full Text
View/download PDF

33. Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma

Author

Mularoni, Valentina, primary, Donati, Benedetta, additional, Tameni, Annalisa, additional, Manicardi, Veronica, additional, Reggiani, Francesca, additional, Sauta, Elisabetta, additional, Zanelli, Magda, additional, Tigano, Marco, additional, Vitale, Emanuele, additional, Torricelli, Federica, additional, Ascani, Stefano, additional, Martino, Giovanni, additional, Inghirami, Giorgio, additional, Sanguedolce, Francesca, additional, Ruffini, Alessia, additional, Bavieri, Alberto, additional, Luminari, Stefano, additional, Pizzi, Marco, additional, Dei Tos, Angelo Paolo, additional, Fesce, Cinzia, additional, Neri, Antonino, additional, Ciarrocchi, Alessia, additional, and Fragliasso, Valentina, additional

Published
2023
Full Text
View/download PDF

34. Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi

Author

Nizzoli, Maria E., primary, Manni, Martina, additional, Ghiggi, Chiara, additional, Pulsoni, Alessandro, additional, Musuraca, Gerardo, additional, Merli, Michele, additional, Califano, Catello, additional, Bari, Alessia, additional, Massaia, Massimo, additional, Conconi, Annarita, additional, Musto, Pellegrino, additional, Mannina, Donato, additional, Perrone, Tommasina, additional, Re, Francesca, additional, Galimberti, Sara, additional, Gini, Guido, additional, Capponi, Monia, additional, Vitolo, Umberto, additional, Usai, Sara V., additional, Stefani, Piero M., additional, Ballerini, Filippo, additional, Liberati, Anna M., additional, Pennese, Elsa, additional, Pastore, Domenico, additional, Skrypets, Tetiana, additional, Catellani, Hillary, additional, Marcheselli, Luigi, additional, Federico, Massimo, additional, and Luminari, Stefano, additional

Published
2023
Full Text
View/download PDF

37. The Role of Geriatric Assessment in the Management of Diffuse Large B-Cell Lymphoma.

Author

Merli, Francesco, Pozzi, Stefano, Catellani, Hillary, Barbieri, Emiliano, and Luminari, Stefano

Subjects
PATIENT autonomy, FUNCTIONAL status, GERIATRIC assessment, B cell lymphoma, SARCOPENIA, DISEASE management, COMORBIDITY, OLD age
Abstract

Simple Summary: The treatment choice for an older patient with diffuse large B-cell lymphoma (DLBCL) is challenging due to the complexity of the patient. Among the several available tools to evaluate an older subject with DLBCL, the simplified geriatric assessment (sGA) categorizes patients as fit, unfit, or frail and has been validated to predict the risk of death. The elderly prognostic index (EPI), which combines sGA and IPI scores and hemoglobin level, is the first prognostic score for older patients, with three risk groups for survival. New validated tools will help physicians choose the best treatment for elderly patients with DLBCL, further contributing to improving the personalized approach to elderly subjects. The treatment choice for an older patient with diffuse large B-cell lymphoma (DLBCL) depends on many other factors in addition to age, which alone does not reflect the complexity of the aging process. Functional features and comorbidity incidence differ not only between younger and older patients but also among older patients themselves. The comprehensive geriatric assessment (CGA) quickly evaluates fitness status by investigating the patient's different functional areas, degree of autonomy, and presence of comorbidities. Various tools are available to evaluate frailty; which assessment tool to use should be based on the clinical aim. The simplified geriatric assessment (sGA) from the elderly project by the Fondazione Italiana Linfomi, prospectively tested on the largest number of patients, categorizes patients as fit, unfit, or frail, with a decreasing rate of overall survival. The elderly prognostic index (EPI), which combines sGA and IPI scores and hemoglobin level, is the first prognostic score for older patients, with three risk groups for survival. Future GAs should consider new parameters, including sarcopenia, which appears to be inversely related to survival. New tools based on prospective studies can help physicians choose the best treatment in light of the individual patient's characteristics. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

39. Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Author

Gotti, Manuel, primary, Sciarra, Roberta, additional, Pulsoni, Alessandro, additional, Merli, Francesco, additional, Luminari, Stefano, additional, Zerbi, Caterina, additional, Trentin, Livio, additional, Re, Alessandro, additional, Rusconi, Chiara, additional, Viviani, Simonetta, additional, Rossi, Andrea, additional, Cocito, Federica, additional, Botto, Barbara, additional, Meli, Erika, additional, Pinto, Antonello, additional, Dogliotti, Irene, additional, Gini, Guido, additional, Puccini, Benedetta, additional, Ricci, Francesca, additional, Nassi, Luca, additional, Fabbri, Alberto, additional, Liberati, Anna Marina, additional, Merli, Michele, additional, Filippi, Andrea Riccardo, additional, Bonfichi, Maurizio, additional, Zoboli, Valentina, additional, Tartaglia, Germana, additional, Annechini, Giorgia, additional, D’Elia, Gianna Maria, additional, Del Giudice, Ilaria, additional, Alvarez, Isabel, additional, Visentin, Andrea, additional, Pravato, Stefano, additional, Dalceggio, Daniela, additional, Pagani, Chiara, additional, Ferrari, Silvia, additional, Cristinelli, Caterina, additional, Lazic, Tanja, additional, Ferretti, Virginia Valeria, additional, Ricardi, Umberto, additional, and Arcaini, Luca, additional

Published
2023
Full Text
View/download PDF

40. Additional Table I from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

Author

Galimberti, Sara, primary, Luminari, Stefano, primary, Ciabatti, Elena, primary, Grassi, Susanna, primary, Guerrini, Francesca, primary, Dondi, Alessandra, primary, Marcheselli, Luigi, primary, Ladetto, Marco, primary, Piccaluga, Pier Paolo, primary, Gazzola, Anna, primary, Mannu, Claudia, primary, Monitillo, Luigia, primary, Mantoan, Barbara, primary, Del Giudice, Ilaria, primary, Della Starza, Irene, primary, Cavalli, Marzia, primary, Arcaini, Luca, primary, Tucci, Alessandra, primary, Palumbo, Giuseppe Alberto, primary, Rigacci, Luigi, primary, Pulsoni, Alessandro, primary, Vitolo, Umberto, primary, Boccomini, Carola, primary, Vallisa, Daniele, primary, Bertoldero, Giovanni, primary, Gaidano, Gianluca, primary, Musto, Pellegrino, primary, Petrini, Mario, primary, and Federico, Massimo, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Data from A Gene Expression–based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients

Author

Luminari, Stefano, primary, Donati, Benedetta, primary, Casali, Massimiliano, primary, Valli, Riccardo, primary, Santi, Raffaella, primary, Puccini, Benedetta, primary, Kovalchuk, Sofya, primary, Ruffini, Alessia, primary, Fama, Angelo, primary, Berti, Valentina, primary, Fragliasso, Valentina, primary, Zanelli, Magda, primary, Vergoni, Federica, primary, Versari, Annibale, primary, Rigacci, Luigi, primary, Merli, Francesco, primary, and Ciarrocchi, Alessia, primary

Published
2023
Full Text
View/download PDF

42. Supplemental Figure Legend from Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

Author

Galimberti, Sara, primary, Luminari, Stefano, primary, Ciabatti, Elena, primary, Grassi, Susanna, primary, Guerrini, Francesca, primary, Dondi, Alessandra, primary, Marcheselli, Luigi, primary, Ladetto, Marco, primary, Piccaluga, Pier Paolo, primary, Gazzola, Anna, primary, Mannu, Claudia, primary, Monitillo, Luigia, primary, Mantoan, Barbara, primary, Del Giudice, Ilaria, primary, Della Starza, Irene, primary, Cavalli, Marzia, primary, Arcaini, Luca, primary, Tucci, Alessandra, primary, Palumbo, Giuseppe Alberto, primary, Rigacci, Luigi, primary, Pulsoni, Alessandro, primary, Vitolo, Umberto, primary, Boccomini, Carola, primary, Vallisa, Daniele, primary, Bertoldero, Giovanni, primary, Gaidano, Gianluca, primary, Musto, Pellegrino, primary, Petrini, Mario, primary, and Federico, Massimo, primary

Published
2023
Full Text
View/download PDF

45. PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

Author

Barrington, Sally F., Kirkwood, Amy A., Franceschetto, Antonella, Fulham, Michael J., Roberts, Thomas H., Almquist, Helén, Brun, Eva, Hjorthaug, Karin, Viney, Zaid N., Pike, Lucy C., Federico, Massimo, Luminari, Stefano, Radford, John, Trotman, Judith, Fosså, Alexander, Berkahn, Leanne, Molin, Daniel, D'Amore, Francesco, Sinclair, Donald A., Smith, Paul, O'Doherty, Michael J., Stevens, Lindsey, and Johnson, Peter W.

Published
2016
Full Text
View/download PDF

46. Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses

Author

D’Angelo, Alberto, primary, Kilili, Huseyin, additional, Chapman, Robert, additional, Generali, Daniele, additional, Tinhofer, Ingeborg, additional, Luminari, Stefano, additional, Donati, Benedetta, additional, Ciarrocchi, Alessia, additional, Giannini, Riccardo, additional, Moretto, Roberto, additional, Cremolini, Chiara, additional, Pietrantonio, Filippo, additional, Sobhani, Navid, additional, Bonazza, Debora, additional, Prins, Robert, additional, Song, Seung Geun, additional, Jeon, Yoon Kyung, additional, Pisignano, Giuseppina, additional, Cinelli, Mattia, additional, Bagby, Stefan, additional, and Urrutia, Araxi O., additional

Published
2023
Full Text
View/download PDF

47. Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Author

Ceriani, Luca, Martelli, Maurizio, Zinzani, Pier Luigi, Ferreri, Andrés J.M., Botto, Barbara, Stelitano, Caterina, Gotti, Manuel, Cabras, Maria Giuseppina, Rigacci, Luigi, Gargantini, Livio, Merli, Francesco, Pinotti, Graziella, Mannina, Donato, Luminari, Stefano, Stathis, Anastasios, Russo, Eleonora, Cavalli, Franco, Giovanella, Luca, Johnson, Peter W.M., and Zucca, Emanuele

Published
2015
Full Text
View/download PDF

48. Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12

Author

Kuruvilla, John, MacDonald, David A., Kouroukis, C. Tom, Cheung, Matthew, Olney, Harold J., Turner, A. Robert, Anglin, Peter, Seftel, Matthew, Ismail, Walid Sabry, Luminari, Stefano, Couban, Stephen, Baetz, Tara, Meyer, Ralph M., Hay, Annette E., Shepherd, Lois, Djurfeldt, Marina S., Alamoudi, Sameer, Chen, Bingshu E., and Crump, Michael

Published
2015
Full Text
View/download PDF

49. Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)

Author

Tucci, Alessandra, primary, Merli, Francesco, additional, Fabbri, Alberto, additional, Marcheselli, Luigi, additional, Pagani, Chiara, additional, Puccini, Benedetta, additional, Marino, Dario, additional, Zanni, Manuela, additional, Pennese, Elsa, additional, Flenghi, Leonardo, additional, Arcari, Annalisa, additional, Botto, Barbara, additional, Celli, Melania, additional, Mammi, Caterina, additional, Re, Alessandro, additional, Campostrini, Giulia, additional, Tafuri, Agostino, additional, Zilioli, Vittorio R., additional, Cencini, Emanuele, additional, Sartori, Roberto, additional, Bottelli, Chiara, additional, Merli, Michele, additional, Petrucci, Luigi, additional, Gini, Guido, additional, Balzarotti, Monica, additional, Cavallo, Federica, additional, Musuraca, Gerardo, additional, Luminari, Stefano, additional, Rossi, Giuseppe, additional, and Spina, Michele, additional

Published
2022
Full Text
View/download PDF

50. Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Author

Hapgood, Greg, primary, Civallero, Monica, additional, Stepanishyna, Yana, additional, Vose, Julie M., additional, Cabrera, Maria Elena, additional, Advani, Ranjana H., additional, Pileri, Stefano A, additional, Manni, Martina, additional, Horwitz, Steven M., additional, Foss, Francine M., additional, Hitz, Felicitas, additional, Radford, John, additional, Dlouhy, Ivan, additional, Chiattone, Carlos S., additional, Kim, Won-Seog, additional, Skrypets, Tetiana, additional, Nagler, Arnon, additional, Trotman, Judith, additional, Luminari, Stefano, additional, and Federico, Massimo, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results